Ceva Animal Health has launched
Duoflect, a new strength formulation
for the treatment and prevention of
flea and tick infestations in cats and
dogs, and the environment.
Containing a new strength formulation of fipronil and (s)-methoprene,
Duoflect’s duration of action against
fleas is 100 percent longer in cats
(eight weeks) and 13 percent longer in
dogs (nine weeks) than the market-leading fipronil combination, while its
duration of action against ticks is 150
percent longer in cats (five weeks) and
50 percent longer in dogs (six weeks).
It acts against adult fleas on the animal and immature flea stages in the
environment and can be used as part
of a treatment strategy for the control
of flea allergy dermatitis.
Duoflect is available in new, easy-to-use, free-standing pipettes for easier
administration and handling of the pet.
The product is competitively priced
and is available in boxes of three or
six pipettes and in five presentations:
small cats (1-5kg), large cats (>5kg)
and small dogs (2-10kg), medium
dogs (10-20kg), large dogs (20-40kg)
and extra-large dogs (40-60kg). It is
suitable for cats and dogs from eight
weeks of age.
